Baird Maintains Inovalon Holdings Inc to Neutral with Price Target $14.00

Brokerage firm Baird Maintains its rating on Inovalon Holdings Inc(NASDAQ:INOV). In a research note issued to the investors, the brokerage major Lowers the price-target to $14.00 per share. The shares have been rated Neutral. The rating by Baird was issued on Sep 23, 2016.

In a different note, On Aug 16, 2016, KeyBanc said it Maintains its rating on Inovalon Holdings Inc. In the research note, the firm Lowers the price-target to $26.00 per share. The shares have been rated ‘Overweight’ by the firm. On Aug 4, 2016, PiperJaffray said it Downgrades its rating on Inovalon Holdings Inc. The shares have been rated ‘Underweight’ by the firm. On Aug 4, 2016, Goldman Sachs said it Downgrades its rating on Inovalon Holdings Inc. In the research note, the firm Lowers the price-target to $25.00 per share. The shares have been rated ‘Neutral’ by the firm. On Aug 4, 2016, William Blair said it Downgrades its rating on Inovalon Holdings Inc. The shares have been rated ‘Market Perform’ by the firm. On Aug 4, 2016, Citigroup said it Maintains its rating on Inovalon Holdings Inc. In the research note, the firm Lowers the price-target to $18.00 per share. The shares have been rated ‘Neutral’ by the firm.

Inovalon Holdings Inc (INOV) shares turned negative on Tuesdays trading session with the shares closing down -0.19 points or -1.29% at a volume of 8,91,924. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $14.88. The peak price level was also seen at $14.88 while the days lowest was $14.49. Finally the shares closed at $14.59. The 52-week high of the shares is $23.87 while the 52-week low is $13.85. According to the latest information available, the market cap of the company is $2,224 M.

Inovalon Holdings Inc(INOV) last announced its earnings results on Aug 3, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $123.83M. Analysts had an estimated revenue of $126.86M. Earnings per share were $0.14. Analysts had estimated an EPS of $0.14.

Several Insider Transactions has been reported to the SEC. On Sep 19, 2016, William D Green (director) purchased 30,000 shares at $16.22 per share price.Also, On Sep 9, 2016, William J Jr Teuber (director) purchased 60,000 shares at $16.46 per share price.On Sep 9, 2016, Shauna L Vernal (Chief Legal Officer) sold 31,593 shares at $0.00 per share price, according to the Form-4 filing with the securities and exchange commission.

Inovalon Holdings Inc. is a technology company. The Company combines advanced cloud-based data analytics and data-driven intervention platforms to provide services for health plans hospitals physicians patients pharmaceutical companies and researchers. Through its datasets integration technologies predictive analytics and subject matter expertise the Company delivers platforms. Its analytics identify gaps in care quality data integrity and financial performance while providing clients with capabilities to resolve these gaps. The Company’s data analytics and intervention platforms consist of four primary components: data integration advanced analytics intervention platforms and business processing. This system manages the process of defining and configuring industry data feeds from its clients and partners including electronic health records laboratory pharmacy patient reported claims paper based medical records biometric and hospital data feeds.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Inovalon Holdings Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Inovalon Holdings Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.